- Disappointment over outlook for second half of fiscal year
- Analysts divided on valuation and growth potential
- Conflicting opinions on buying opportunity
Affirm Holdings Inc.’s stock has taken a hit recently after its latest earnings report. Despite beating expectations for its fiscal second-quarter results, the company’s outlook for the second half of the fiscal year has raised concerns among investors. This has sparked a debate among analysts about the valuation and growth potential of Affirm. As a result, the stock has seen a significant decline in value.
Disappointment over Outlook
Piper Sandler’s Kevin Barker noted that while Affirm surpassed expectations for the fiscal second quarter, its outlook for the second half of the year implied a slowdown in growth across various metrics. This caused disappointment among investors, as it set the bar too high for the company. As a result, Affirm’s stock has faced downward pressure.
Wells Fargo’s Andrew Bauch believes that valuation debates surrounding Affirm are “fruitless” due to the lack of true publicly traded peers. He acknowledges that bullish investors are impressed by the company’s recent execution, but also highlights the difficulty of owning shares given the elevated valuation levels. Morgan Stanley’s James Faucette supports this viewpoint, deeming Affirm’s stock to be overvalued. He raises concerns about the company’s ability to close the monetization gap with Capital One and maintain revenue growth, which may prove challenging.
Conflicting Opinions on Buying Opportunity
While some analysts express concerns about Affirm’s valuation, Mizuho’s Dan Dolev sees the recent selloff as a buying opportunity. He believes that the company’s outlook is easily achievable and values Affirm at 8 times estimated revenue for calendar 2025. Dolev considers Affirm to be one of the most innovative names in their coverage universe and justifies the premium in valuation.
As Affirm’s stock continues to sink, the debate over its valuation and growth potential remains ongoing. Analysts have expressed conflicting opinions, with some believing the stock is overvalued while others see it as a buying opportunity. The market will continue to monitor Affirm’s performance and its ability to meet its projected growth targets. Shareholders and investors should stay informed and evaluate the company’s prospects carefully.
[em]What are your thoughts on Affirm’s stock and its valuation? Share your opinions in the comments below.[/em]